These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
226 related articles for article (PubMed ID: 33629099)
21. Acid suppression and the risk of Clostridium difficile infection. Mezoff EA; Cohen MB J Pediatr; 2013 Sep; 163(3):627-30. PubMed ID: 23759424 [No Abstract] [Full Text] [Related]
22. Proton pump Inhibitors and Risk of Enteric Infection in Inflammatory Bowel Disease: A Self-controlled Case Series. Varma S; Trudeau SJ; Li J; Freedberg DE Inflamm Bowel Dis; 2024 Jan; 30(1):38-44. PubMed ID: 36917215 [TBL] [Abstract][Full Text] [Related]
23. Risk of Clostridium difficile Infection with the Use of a Proton Pump Inhibitor for Stress Ulcer Prophylaxis in Critically Ill Patients. Ro Y; Eun CS; Kim HS; Kim JY; Byun YJ; Yoo KS; Han DS Gut Liver; 2016 Jul; 10(4):581-6. PubMed ID: 27021503 [TBL] [Abstract][Full Text] [Related]
24. Proton pump inhibitors therapy and risk of Clostridium difficile infection: Systematic review and meta-analysis. Trifan A; Stanciu C; Girleanu I; Stoica OC; Singeap AM; Maxim R; Chiriac SA; Ciobica A; Boiculese L World J Gastroenterol; 2017 Sep; 23(35):6500-6515. PubMed ID: 29085200 [TBL] [Abstract][Full Text] [Related]
25. Bolukcu S; Hakyemez IN; Gultepe BS; Okay G; Durdu B; Koc MM; Aslan T Saudi J Gastroenterol; 2019; 25(6):384-389. PubMed ID: 31793457 [TBL] [Abstract][Full Text] [Related]
26. Updated meta-analysis of controlled observational studies: proton-pump inhibitors and risk of Clostridium difficile infection. Cao F; Chen CX; Wang M; Liao HR; Wang MX; Hua SZ; Huang B; Xiong Y; Zhang JY; Xu YL J Hosp Infect; 2018 Jan; 98(1):4-13. PubMed ID: 28842261 [TBL] [Abstract][Full Text] [Related]
27. The evaluation of Clostridium difficile infection (CDI) in a community hospital. Daniel A; Rapose A J Infect Public Health; 2015; 8(2):155-60. PubMed ID: 25301221 [TBL] [Abstract][Full Text] [Related]
28. Implementation of Global Strategies to Prevent Hospital-Onset Clostridium difficile Infection: Targeting Proton Pump Inhibitors and Probiotics. Lewis PO; Lundberg TS; Tharp JL; Runnels CW Ann Pharmacother; 2017 Oct; 51(10):848-854. PubMed ID: 28821215 [TBL] [Abstract][Full Text] [Related]
29. Proton-pump inhibitors and the risk of Clostridium difficile-associated diarrhea in high-risk antibiotics users: A population-based case-crossover study. Hong SH; Lee EK; Shin JY Pharmacoepidemiol Drug Saf; 2019 Apr; 28(4):479-488. PubMed ID: 30848536 [TBL] [Abstract][Full Text] [Related]
30. Association between proton pump inhibitor therapy and clostridium difficile infection: a contemporary systematic review and meta-analysis. Tleyjeh IM; Bin Abdulhak AA; Riaz M; Alasmari FA; Garbati MA; AlGhamdi M; Khan AR; Al Tannir M; Erwin PJ; Ibrahim T; Allehibi A; Baddour LM; Sutton AJ PLoS One; 2012; 7(12):e50836. PubMed ID: 23236397 [TBL] [Abstract][Full Text] [Related]
31. Proton Pump Inhibitors and the Risk for Hospital-Acquired Clostridium difficile Infection. Barletta JF; El-Ibiary SY; Davis LE; Nguyen B; Raney CR Mayo Clin Proc; 2013 Oct; 88(10):1085-90. PubMed ID: 24012413 [TBL] [Abstract][Full Text] [Related]
32. Burden of Clostridium difficile infection between 2010 and 2013: Trends and outcomes from an academic center in Eastern Europe. Kurti Z; Lovasz BD; Mandel MD; Csima Z; Golovics PA; Csako BD; Mohas A; Gönczi L; Gecse KB; Kiss LS; Szathmari M; Lakatos PL World J Gastroenterol; 2015 Jun; 21(21):6728-35. PubMed ID: 26074711 [TBL] [Abstract][Full Text] [Related]
33. Risk and Severity of Hospital-Acquired Clostridium difficile Infection in Patients Taking Proton Pump Inhibitors. Lewis PO; Litchfield JM; Tharp JL; Garcia RM; Pourmorteza M; Reddy CM Pharmacotherapy; 2016 Sep; 36(9):986-93. PubMed ID: 27455386 [TBL] [Abstract][Full Text] [Related]
34. Secular trends in the epidemiology of Clostridium difficile infection (CDI) at a tertiary care hospital in Barcelona, 2006-2015: A prospective observational study. Larrainzar-Coghen T; Rodríguez-Pardo D; Fernández-Hidalgo N; Puig-Asensio M; Pigrau C; Ferrer C; Rodríguez V; Bartolomé R; Campany D; Almirante B Anaerobe; 2018 Jun; 51():54-60. PubMed ID: 29655966 [TBL] [Abstract][Full Text] [Related]
35. Risk of Clostridium difficile infection with acid suppressing drugs and antibiotics: meta-analysis. Kwok CS; Arthur AK; Anibueze CI; Singh S; Cavallazzi R; Loke YK Am J Gastroenterol; 2012 Jul; 107(7):1011-9. PubMed ID: 22525304 [TBL] [Abstract][Full Text] [Related]
36. Clostridium difficile infection in the community: are proton pump inhibitors to blame? Freedberg DE; Abrams JA World J Gastroenterol; 2013 Oct; 19(40):6710-3. PubMed ID: 24187445 [TBL] [Abstract][Full Text] [Related]
37. Proton pump inhibitors and risk of Clostridium difficile infection: association or causation? Villafuerte-Gálvez JA; Kelly CP Curr Opin Gastroenterol; 2018 Jan; 34(1):11-18. PubMed ID: 29095766 [TBL] [Abstract][Full Text] [Related]
38. Do the types and routes of proton pump inhibitor treatments affect Lee P; Fike D; Yang H; Hall RG; Pass S; Alvarez CA Expert Rev Clin Pharmacol; 2021 Mar; 14(3):399-404. PubMed ID: 33576287 [No Abstract] [Full Text] [Related]
39. Association between proton pump inhibitor therapy and Clostridium difficile infection in a meta-analysis. Deshpande A; Pant C; Pasupuleti V; Rolston DD; Jain A; Deshpande N; Thota P; Sferra TJ; Hernandez AV Clin Gastroenterol Hepatol; 2012 Mar; 10(3):225-33. PubMed ID: 22019794 [TBL] [Abstract][Full Text] [Related]
40. Risk factors for Clostridium difficile infection in pediatric inpatients: A meta-analysis and systematic review. Anjewierden S; Han Z; Foster CB; Pant C; Deshpande A Infect Control Hosp Epidemiol; 2019 Apr; 40(4):420-426. PubMed ID: 30841948 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]